Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.
Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan ...
Hosted on MSN35m
Inspiring Story of a Terminally Ill Woman Raising Hope and Funds
Meet the amazing woman, who despite her rare and devastating illness, dedicated her final days to charity, raising awareness ...